NOVATO, Calif.– QT Imaging Holdings, Inc. (OTCQB:QTIH) (the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce today that it successfully uplisted to the OTCQB Venture Market (“OTCQB”). The uplisting application has been approved by OTC Markets Group Inc., and the stock commenced trading on the OTCQB starting on Tuesday, March 11. OTCQB exchange will increase the Company’s value, visibility, and transparency.
QT Imaging Holdings, Inc. is a public (OTCQB: QTIH) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience.
Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.
